The Partnership develops and supports collaborative research projects between CCNY and MSKCC investigators. The overall objectives of these research collaborations are twofold: to bring cancer research projects, primarily being conducted at MSKCC, to more racially, ethnically, and socioeconomically diverse populations; and to encourage scientists at CCNY to expand their work and engage in cancer-related research. This approach builds on the strengths of the two institutions and addresses cancer health disparities in two ways. Currently, the Partnership funds collaborative studies in cell biology, immunology, health disparities, and biomedical research, and includes one full research project, eight pilot research projects, and four pre-pilot projects, as well as two Administrative Supplements awarded to the Partnership through the American Recovery and Reinvestment Act (ARRA).
If you would like to learn more about the Partnership’s research program, please contact Alexa Berk, Clinical Research Manager, at firstname.lastname@example.org.
Development of Novel Combinatorial Chemotherapeutic Strategies
CCNY PI: Caplan, A.
MSKCC PI: Rosen, N.
Molecular Mechanisms of Chemotherapy-Induced Cognitive Decline
CCNY PI: Hubbard, K.
MSKCC PI: Ahles, T.